giritinib price in india

Generic drugs of Gilteritinib are currently produced and sold overseas. Currently, only the Laos version of the generic drug is produced, and there is no Indian version of the generic drug of Gilteritinib produced and marketed. Common manufacturers include Laos Lucius Pharmaceuticals, Daxiong Pharmaceutical Factory, etc. The ingredients of their drugs are basically the same as those of original drugs sold domestically and abroad. For example, the price of 40mg*84 tablets per box produced by Laos Pharmaceutical Factory is more than 4,000 yuan (the price may fluctuate due to the exchange rate).

Giritinib is an FLT3 inhibitor approved for the treatment of acute myeloid leukemia (AML) and is currently approved for the treatment of relapsed/refractory FLT3-positive disease. In this setting, geritinib provided approximately twice the survival benefit as salvage chemotherapy. Additionally, giritinib improves patients' quality of life because it is administered orally to facilitate outpatient treatment. Of note, giritinib is beneficial only in patients with FLT3-positive AML, thus supporting the practice of testing all patients for FLT3 positivity before initiating treatment. Physicians should be aware of common laboratory and ECG monitoring parameters in patients initiating geritinib treatment, especially in the first 3 months.

The original drug of giritinib has been launched in China, but it has not yet been included in the medical insurance. The price of each box of 40mg*42 tablets may be more than 20,000 yuan, and the price of the Hong Kong version of the original drug is about 90,000 yuan per box. The price of the European version of the original drug, 40mg*84 tablets, per box listed overseas is around RMB 210,000 (the price may fluctuate due to exchange rates), which is very expensive. For more overseas drug information and specific prices, please consult Yaode Medical Consultant.